Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride Augmentation for Clozapine-resistant Schizophrenia
NCT01105481Phase 4Completed
- Sponsor
- National Health Research Institutes
- Start
- May 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Amisulpride Add-on with Placebo Add-on (2 arms). Primary endpoint: Positive and Negative Symptom Scale Total Score Change at 12 weeks. Started May 2006; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01105481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01105481.